8- References
1. Hui D, Madani T, Ntoumi F, et al. The continuing 2019-nCoV epidemic
threat of novel coronaviruses to global health-The latest 2019 novel
coronavirus outbreak in Wuhan, China. International journal of
infectious diseases: IJID: official publication of the International
Society for Infectious Diseases. 2020;91:264.
2. Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA.
Isolation of a novel coronavirus from a man with pneumonia in Saudi
Arabia. New England Journal of Medicine. 2012;367(19):1814-1820.
3. Woo PC, Lau SK, Chu C-m, et al. Characterization and complete genome
sequence of a novel coronavirus, coronavirus HKU1, from patients with
pneumonia. Journal of virology. 2005;79(2):884-895.
4. van der Hoek L, Pyrc K, Jebbink MF, et al. Identification of a new
human coronavirus. Nature medicine. 2004;10(4):368-373.
5. van der Hoek L. Human coronaviruses: what do they cause?Antiviral therapy. 2007;12(4 Pt B):651.
6. Bradburne A, Bynoe M, Tyrrell D. Effects of a” new” human respiratory
virus in volunteers. British medical journal. 1967;3(5568):767.
7. Zhong N, Zheng B, Li Y, et al. Epidemiology and cause of severe acute
respiratory syndrome (SARS) in Guangdong, People’s Republic of China, in
February, 2003. The Lancet. 2003;362(9393):1353-1358.
8. Biscayart C, Angeleri P, Lloveras S, Chaves TDSS, Schlagenhauf P,
Rodríguez-Morales AJ. The next big threat to global health? 2019 novel
coronavirus (2019-nCoV): What advice can we give to travellers? –
Interim recommendations January 2020, from the Latin-American society
for Travel Medicine (SLAMVI). Travel Medicine and Infectious
Disease. 2020.
9. Bal A, Destras G, Gaymard A, et al. Molecular characterization of
SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino-acid
deletion in nsp2 (Asp268Del). bioRxiv.2020:2020.2003.2019.998179.
10. Lu H, Stratton CW, Tang YW. Outbreak of Pneumonia of Unknown
Etiology in Wuhan China: the Mystery and the Miracle. Journal of
Medical Virology.
11. Bogoch II, Watts A, Thomas-Bachli A, Huber C, Kraemer MU, Khan K.
Pneumonia of Unknown Etiology in Wuhan, China: Potential for
International Spread Via Commercial Air Travel. Journal of Travel
Medicine. 2020.
12. Wevers BA, van der Hoek L. Recently discovered human coronaviruses.Clinics in laboratory medicine. 2009;29(4):715-724.
13. Luk HK, Li X, Fung J, Lau SK, Woo PC. Molecular epidemiology,
evolution and phylogeny of SARS coronavirus. Infection, Genetics
and Evolution. 2019.
14. van Boheemen S, de Graaf M, Lauber C, et al. Genomic
characterization of a newly discovered coronavirus associated with acute
respiratory distress syndrome in humans. MBio.2012;3(6):e00473-00412.
15. Forni D, Cagliani R, Clerici M, Sironi M. Molecular evolution of
human coronavirus genomes. Trends in microbiology.2017;25(1):35-48.
16. Su S, Wong G, Shi W, et al. Epidemiology, genetic recombination, and
pathogenesis of coronaviruses. Trends in microbiology.2016;24(6):490-502.
17. Monto AS. Medical reviews. Coronaviruses. The Yale journal of
biology and medicine. 1974;47(4):234.
18. Azhar EI, Hui DSC, Memish ZA, Drosten C, Zumla A. The Middle East
Respiratory Syndrome (MERS). Infectious Disease Clinics of North
America. 2019;33(4):891-905.
19. Reusken CB, Haagmans BL, Müller MA, et al. Middle East respiratory
syndrome coronavirus neutralising serum antibodies in dromedary camels:
a comparative serological study. The Lancet infectious diseases.2013;13(10):859-866.
20. Division of Viral Diseases CfDCaP, 2020.
https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-panel-primer-probes.html.
21. Chan JF-W, Yuan S, Kok K-H, et al. A familial cluster of pneumonia
associated with the 2019 novel coronavirus indicating person-to-person
transmission: a study of a family cluster. The Lancet.2020;395(10223):514-523.
22. Nao N, Shirato K, Katano H, Matsuyama S, Takeda M. Detection of
second case of 2019-nCoV infection in Japan (corrected version).
In:2020.
23. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients
with pneumonia in China, 2019. New England Journal of Medicine.2020.
24. Wu A, Peng Y, Huang B, et al. Genome Composition and Divergence of
the Novel Coronavirus (2019-nCoV) Originating in China. Cell Host
& Microbe. 2020.
25. Chen Y, Liu Q, Guo D. Coronaviruses: genome structure, replication,
and pathogenesis. J Med Virol. 2020.
26. Hussain S, Chen Y, Yang Y, et al. Identification of novel subgenomic
RNAs and noncanonical transcription initiation signals of severe acute
respiratory syndrome coronavirus. Journal of virology.2005;79(9):5288-5295.
27. Glowacka I, Bertram S, Müller MA, et al. Evidence that TMPRSS2
activates the severe acute respiratory syndrome coronavirus spike
protein for membrane fusion and reduces viral control by the humoral
immune response. Journal of virology. 2011;85(9):4122-4134.
28. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell
entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven
protease inhibitor. Cell. 2020.
29. Liu Z, Xiao X, Wei X, et al. Composition and divergence of
coronavirus spike proteins and host ACE2 receptors predict potential
intermediate hosts of SARS-CoV-2. J Med Virol. 2020.
30. Chan JF-W, Kok K-H, Zhu Z, et al. Genomic characterization of the
2019 novel human-pathogenic coronavirus isolated from a patient with
atypical pneumonia after visiting Wuhan. Emerging Microbes &
Infections. 2020;9(1):221-236.
31. Eden J-S, Rockett R, Carter I, et al. An emergent clade of
SARS-CoV-2 linked to returned travellers from Iran. bioRxiv.2020.
32. Sardar R, Satish D, Birla S, Gupta D. Comparative analyses of
SAR-CoV2 genomes from different geographical locations and other
coronavirus family genomes reveals unique features potentially
consequential to host-virus interaction and pathogenesis.bioRxiv. 2020:2020.2003.2021.001586.
33. Xiao M, Liu X, Ji J, et al. Multiple approaches for massively
parallel sequencing of HCoV-19 genomes directly from clinical samples.bioRxiv. 2020.